Search
for
Sort by
Research 331–360 of 1000+
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Stem Cell Competition for Niche Occupancy: Emerging Themes and Mechanisms
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Current and future pharmacotherapy for alopecia areata
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Pharmacotherapy of alopecia areata
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Tofacitinib therapy for children with severe alopecia areata
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Pharmacological Treatment of Alopecia
- Alopecia Areata and Alopecia Areata Incognita
- Research Progress on the Application of Stem Cells in Hair Regeneration
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Novel therapies for alopecia areata: The era of rational drug development
- Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment